AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer

To determine the optimum doses of AZD2281 and carboplatin that can safely be used in patients with breast and ovarian cancer. To evaluate the response of the tumor to the drug combination and determine the side effects of the treatment.